文献速递其他结缔组织病

涎腺超声与唇腺/腮腺活检及分类标准在疑似原发性干燥综合征中的比较

Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sjögren's syndrome.
PubMed 文献 · Ann Rheum Dis · 2017-07-28

该前瞻性队列纳入103例临床疑似原发性干燥综合征(pSS)的连续门诊患者,采用Hocevar评分系统行涎腺超声(sUS),并与腮腺及唇腺活检、唾液流率、抗SSA/Ro抗体及AECG、ACR、ACR-EULAR分类标准比较。sUS与腮腺活检的绝对一致率为83%、与唇腺活检为79%;与AECG、ACR、ACR-EULAR分类标准比较的绝对一致率分别为82%、86%、80%,敏感度分别为71%、77%、67%,特异度分别为92%、92%、94%。sUS阳性联合抗SSA/Ro抗体阳性对pSS分类具有高预测价值。

要点

  • sUS与腮腺活检绝对一致率83%,稍高于唇腺活检的79%。
  • sUS阳性预测分类,但sUS阴性不能排除分类。
  • sUS阳性联合抗SSA/Ro抗体阳性对pSS分类有高预测价值。

核心结论

  • sUS与涎腺活检的绝对一致率腮腺略高于唇腺,sUS阳性联合抗SSA/Ro抗体阳性可高度预测pSS分类。

研究设计与样本

  • 前瞻性起始队列研究,纳入103例临床疑似pSS的连续门诊患者,行sUS并按Hocevar评分系统评分(总分范围0-48)。

主要发现

  • sUS与腮腺活检绝对一致率83%,与唇腺活检79%。
  • sUS与AECG分类标准比较:绝对一致率82%,敏感度71%,特异度92%。
  • sUS与ACR分类标准比较:绝对一致率86%,敏感度77%,特异度92%。
  • sUS与ACR-EULAR分类标准比较:绝对一致率80%,敏感度67%,特异度94%。
  • sUS阳性预测分类,但sUS阴性不排除分类;sUS阳性联合抗SSA/Ro抗体阳性或sUS阴性联合抗SSA/Ro抗体阴性对pSS或非pSS分类有高预测价值。

关键数值与推荐

  • sUS采用Hocevar评分系统,评估腺体回声性、均匀性、低回声区、高回声反射及腺体边界清晰度,总分范围0-48。
  • sUS与AECG分类标准比较的敏感度71%、特异度92%、绝对一致率82%。
  • sUS与ACR分类标准比较的敏感度77%、特异度92%、绝对一致率86%。
  • sUS与ACR-EULAR分类标准比较的敏感度67%、特异度94%、绝对一致率80%。

临床怎么用

  • 临床疑似pSS患者可行sUS作为无创评估,sUS阳性联合抗SSA/Ro抗体阳性支持pSS分类。
  • sUS阴性结果不能排除pSS分类,仍需结合活检、抗体及分类标准综合判断。

局限性

  • 本研究为单中心前瞻性起始队列,样本量103例,结论需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the validity of ultrasound of major salivary glands (sUS) compared with parotid and labial gland biopsies, sialometry, anti-SSA/Ro antibody status and classification criteria in patients clinically suspected with primary Sjögren's syndrome (pSS). METHODS: 103 consecutive outpatients with clinically suspected pSS underwent sUS. Parenchymal echogenicity, homogeneity, hypoechogenic areas, hyperechogenic reflections and clearness of salivary gland border were scored according to the Hocevar scoring system. Total ultrasound score was calculated as the sum of these domains (range 0-48). RESULTS: Absolute agreement between sUS and parotid (83%) and labial (79%) gland biopsy outcome was good. Negative sUS predicts negative parotid gland biopsy, and positive sUS predicts positive labial gland biopsy. Compared with the American European Consensus Group (AECG) classification, sUS showed an absolute agreement of 82%, sensitivity of 71% and specificity of 92%. Compared with the American College of Rheumatology (ACR) classification, absolute agreement was 86%, sensitivity was 77% and specificity was 92%. Compared with the ACR-European League Against Rheumatism (EULAR) classification, absolute agreement was 80%, sensitivity was 67% and specificity was 94%. Positive sUS predicts classification, but negative sUS does not exclude classification. The combination of positive sUS with presence of anti-SSA/Ro antibodies or negative sUS with absence of anti-SSA/Ro antibodies showed a high predictive value for classification as pSS or non-pSS. CONCLUSION: In our prospective inception cohort study derived from daily clinical practice, absolute agreement between sUS and salivary gland biopsies was slightly higher for parotid compared with labial gland biopsies. The combination of positive sUS and presence of anti-SSA/Ro antibodies highly predicts classification according to the AECG, ACR and ACR-EULAR classification criteria.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Mossel E, Delli K, van Nimwegen JF, et al. Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sjögren's syndrome. Ann Rheum Dis. 2017. PMID: 28754802. doi:10.1136/annrheumdis-2017-211250

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。